Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Agile Therapeutics Announces Proposed Offering of Common Stock
-
RESI Shareholders Group Nominates Directors for Election at Altisource Residential's Annual Meeting
-
Ardelyx Announces Closing of Public Offering Including Exercise of Underwriters' Right to Purchase Additional Shares
-
Cantor Fitzgerald Upgrades Verastem (VSTM) to Spec. Buy
-
GFI Group Inc. Announces Successful Completion of its Consent Solicitation with Respect to its 8.375% Senior Notes due 2018
-
Orchid Island Capital Announces January 2016 Monthly Dividend and December 31, 2015 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Upgrades FS Investment (FSIC) to Buy
-
Cyclacel Reviews 2015 Achievements and Announces Key Business Objectives for 2016
-
Sainsbury's deal with Argos would help online prowess
-
Cantor Fitzgerald Starts Agile Therapeutics (AGRX) at Buy
-
Ardelyx (ARDX) Prices 7.5M Common Stock Offering at $10/Share
-
Ardelyx Announces Pricing of Public Offering of Common Stock
-
Ardelyx (ARDX) to Offer $75M in Common Stock
-
Ardelyx Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald & Co. Hires Kevin Reynolds and Timothy Swift To Join Debt Capital Markets Team
-
Onconova Therapeutics (ONTX) Announcs Termination of Sales Agreement with Cantor Fitzgerald
-
Cantor Fitzgerald & Co.'s Youssef Squali and Naved Khan Named in Top 1 Percentile of TipRanks' Annual Ranking of Wall Street Research Analysts for 2015
-
Akebia Therapeutics (AKBA) Terminates Controlled Equity Sales Agreement with Cantor Fitzgerald
-
Cantor Fitzgerald Upgrades Sunesis Pharmaceuticals Inc. (SNSS) to Spec. Buy
-
Corvus Pharmaceuticals (CRVS) Files $115M IPO
-
SouFun Holdings (SFUN) Names Kent Huang as Permanent CFO
-
SOUFUN (FANG) Enhances Management Team with New CFO
-
Cantor Fitzgerald's Rob Chang Interviewed by The Energy Report
-
Form 4 BGC Partners, Inc. For: Dec 21 Filed by: CANTOR FITZGERALD, L. P.
-
Notable Analyst Rating Changes 12/23: (EEFT) (OKE) (DLPH) Upgraded; (MU) (BBBY) (SCS) Downgraded
-
Cantor Fitzgerald Starts SM Energy (SM) at Hold
-
Cantor Fitzgerald Starts QEP Resources (QEP) at Buy
-
Cantor Fitzgerald Starts Newfield Exploration (NFX) at Buy
-
The Life Sciences Report Announces 19 Companies for the 2016 Small-Cap Biotech Watchlist
-
Notable Analyst Rating Changes 12/21: AGR) (CIEN) (AVGO) Upgraded; (DDR) (WTR) (ERIC) Downgraded
-
Cantor Fitzgerald to pay U.S. watchdog $7.3 million for microcap sales
-
FINRA Sanctions Cantor Fitzgerald & Co. $7.3 Million for Selling Billions of Unregistered Microcap Shares, and for Related Supervisory and AML Violations
-
CCRE Achieves Status As The Nation's Fastest Growing Commercial Real Estate Loan Servicer With A $50 Billion Servicing Portfolio
-
UPDATE: Cantor Fitzgerald Starts Rosetta Genomics (ROSG) at Spec. Buy
-
UPDATE: Cantor Fitzgerald Starts Veracyte, Inc (VCYT) at Buy
-
Pre-Open Stock Movers 12/18 (GMLP) (ROSG) (RHT) Higher; (KNX) (ICPT) (KMX) Lower (more...)
-
Cantor Fitzgerald Downgrades Pier 1 Imports (PIR) to Hold
-
Cantor Fitzgerald Starts Axsome Therapeutics (AXSM) at Buy
-
Rambler Metals & Mining PLC Announces Unaudited Consolidated Financial Information For the Quarter Ended October 31, 2015
-
BGC and GFI Complete Sale of Trayport to Intercontinental Exchange
-
Which stock sectors will Fed rate hike help most? History no guide
-
Orchid Island Capital Announces December 2015 Monthly Dividend and November 30, 2015 RMBS Portfolio Characteristics
-
T2 Biosystems (TTOO) Announces Closing of 3.5M Common Stock Offering
-
T2 Biosystems Announces Closing of Public Offering of Common Stock
-
T2 Biosystems Announces Closing of Public Offering of Common Stock
-
Cantor Fitzgerald Upgrades Galena Biopharma (GALE) to Hold
-
Karyopharm Therapeutics (KPTI) Enters $50M Controlled Equity Offering Sales Agreement
-
Form 4 BGC Partners, Inc. For: Nov 04 Filed by: CANTOR FITZGERALD, L. P.
-
Cantor Fitzgerald Starts Markit Ltd. (MRKT) at Hold
-
T2 Biosystems (TTOO) Prices 3.5M Common Stock Offering at $9.75/Share


